• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Portal Capital

edit

Portal Capital is a Cleveland-based private equity investment firm that specializes in small-market private equity investments in Life Science related companies. Founded in 2008 by executives from both Medical Manufacturing and Healthcare Investment Banking, our team offers a combined history of over 50 years of experience in operations, finance, and marketing, and has a successful track record in sourcing, managing, and exiting equity investments through a range of economic cycles and market conditions. Portal Capital typically seeks to deploy $250,000 to $2 million of equity for all, controlling or substantial-minority positions in North American-based early-stage companies through a range of transaction structures - leveraged buyouts, corporate divestitures, recapitalizations, orphaned technologies, build-ups, and growth financings.

Milestones

edit

• 
  Portal Capital invested in Theravasc. (9/27/10)
  Posted 11/3/10 at 11:02pm via medcitynews.com
• 
  Portal Capital invested in COMS Interactive. (3/26/10)
  Posted 7/22/10 at 6:56pm via dowjones.com
• 
  Portal Capital invested in Theravasc. (1/6/10)
  Posted 1/6/10 at 9:52pm via finsmes.com

Investments

Videos

Sources

1. Peripheral artery disease drug developer TheraVasc raises $1.8M (medcitynews.com) [edit]
2. COMS Collecting $4M Series B To Keep Patients Out Of Hospitals (fis.dowjones.com) [edit]
3. TheraVasc Raises $500,000 from JumpStart and Portal Capital (finsmes.com) [edit]